PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Wen Dan Tang improves insomnia-related anxiety

Wen Dan Tang improves insomnia-related anxiety
2014-03-31
(Press-News.org) Ghrelin, a brain-gut peptide that induces anxiety and other abnormal emotions, contributes to the effects of insomnia on emotional behavior. In contrast, the traditional Chinese Medicine remedy Wen Dan Tang reduces insomnia-related anxiety, which may perhaps correspond to changes in the brain-gut axis. This suggests a possible relationship between Wen Dan Tang's pharmacological mechanism and the brain-gut axis. Based on this hypothesis, a research team from Beijing University of Chinese Medicine in China generated a sleep deprivation rat model, and orally administered Wen Dan Tang. Wen Dan Tang significantly reduced insomnia-related anxiety and prevented Ghrelin level decreases following sleep deprivation, especially in the hypothalamus. Increased expression of Ghrelin receptor mRNA in the hypothalamus was also observed, suggesting that reduced anxiety may be a result of Wen Dan Tang's regulation of Ghrelin-Ghrelin receptors. The relevant paper has been published in the Neural Regeneration Research (Vol. 9, No. 2, 2014).

INFORMATION: Article: " Effects of Wen Dan Tang on insomnia-related anxiety and levels of the brain-gut peptide Ghrelin," by Liye Wang, Yuehan Song, Feng Li, Yan Liu, Jie Ma, Meng Mao, Fengzhi Wu, Ying Wu, Sinai Li, Binghe Guan, Xiaolan Liu(Nautical Chinese Medicine Key Subject, Beijing University of Chinese Medicine, Beijing 100029, China) Wang LY, Song YH, Li F, Liu Y, Ma J, Mao M, Wu FZ, Wu Y, Li SN, Guan BH, Liu XL. Effects of Wen Dan Tang on insomnia-related anxiety and levels of the brain-gut peptide Ghrelin. Neural Regen Res. 2014;9(2):205-212.

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
http://www.nrronline.org/

[Attachments] See images for this press release:
Wen Dan Tang improves insomnia-related anxiety

ELSE PRESS RELEASES FROM THIS DATE:

A breakthrough in creating invisibility cloaks, stealth technology

A breakthrough in creating invisibility cloaks, stealth technology
2014-03-31
Controlling and bending light around an object so it appears invisible to the naked eye is the theory behind fictional invisibility cloaks. It may seem easy in Hollywood movies, but is hard to create in real life because no material in nature has the properties necessary to bend light in such a way. Scientists have managed to create artificial nanostructures that can do the job, called metamaterials. But the challenge has been making enough of the material to turn science fiction into a practical reality. The work of Debashis Chanda at the University of Central Florida, ...

Early rehabilitation improves postsurgery neurofunctional outcome in spinal tumor children

2014-03-31
In children, primary spinal tumors comprise 4% of all tumors from the central nervous system. Spinal tumors can present with a variety of clinical signs and symptoms in children such as pain followed by motor regression, gait disturbance, sphincter dysfunction, sensory symptoms, torticollis, and kyphoscoliosis. Treatment of spinal tumors is based on tumor type, but surgical resection is the mainstay. Moreover, physical treatment and rehabilitation implementation are necessary in order to minimize the symptoms of the patients and develop present functions. Prof. Nezire Kose ...

A new study shows that even micro heart attacks are a major problem

2014-03-31
MINNEAPOLIS, MN – March 29, 2014 – Researchers at the Minneapolis Heart Institute at Abbott Northwestern Hospital have found that cardiac magnetic resonance (CMR) imaging may help doctors better identify which patients with mild heart disease are likely to develop more serious heart problems long term. CMR imaging provides supporting information to guide treatment decisions and help doctors provide targeted care for patients at highest risk. The research, led by Minneapolis Heart Institute Foundation Research Fellow Naohiko Nemoto, MD, will be presented at the American ...

Young women: Eat more fruits and vegetables now to protect your heart later

2014-03-31
MINNEAPOLIS, MN – March 29, 2014 – A diet rich in fruits and vegetables for middle-aged adults has been associated with reduced rates of coronary heart disease (CHD), especially in women. Now, research supported by the Minneapolis Heart Institute Foundation (MHIF) shows that for women, what you eat in your 20s may be just as important for your middle-aged heart. The results of the study, aimed at examining the extent to which young adults' diets are linked to cardiovascular health later in life, will be presented at the American College of Cardiology (ACC) meeting in Washington, ...

Fewer deaths with self-expanding TAVR versus surgery at 1 year

2014-03-31
WASHINGTON (March 29, 2014) — Transcatheter aortic valve replacement with a self-expanding valve prosthesis for the first time has demonstrated significantly lower death rates at one year compared with conventional surgical valve replacement in high-risk patients with severe aortic stenosis, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session. Worldwide, an estimated 300,000 people have severe aortic stenosis – a faulty valve in the main artery carrying blood out of the heart – and roughly a third of them are deemed unable ...

Renal denervation shows no benefit in resistant hypertension

2014-03-31
WASHINGTON (March 29, 2014) — Renal denervation fell short of primary and secondary efficacy goals in patients with severe resistant hypertension but did meet the primary safety endpoints, according to keenly awaited data from SYMPLICITY HTN-3 presented at the American College of Cardiology's 63rd Annual Scientific Session. This pivotal trial is the largest study conducted of renal artery denervation as a treatment for resistant hypertension and the most rigorously designed, including blinding and a sham treatment in the control arm. Hypertension increases risks for heart ...

Efforts to curb hospital readmissions take center stage

2014-03-31
WASHINGTON (March 29, 2014) — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular conditions who find themselves back in the hospital after discharge were identified in six new studies presented at the American College of Cardiology's 63rd Annual Scientific Session. One out of five Medicare patients with heart failure is readmitted to the hospital within just one month of discharge, a fact that is not only bad news for patients who would most likely prefer to avoid another hospital stay, but it also places intense economic pressures ...

Primary cardiovascular disease prevention is leaving the office

2014-03-31
MINNEAPOLIS, MN – March 30, 2014 – Early results from HeartBeat Connections, a telemedicine program supported by the Minneapolis Heart Institute Foundation (MHIF), suggest effective primary prevention for cardiovascular disease (CVD) may be achieved with a team-based approach that integrates office visits with supplemental phone coaching. HeartBeat Connections provides dietitian- and nurse-led coaching over the phone to adults at high risk for CVD, with the goal of helping to improve and control key CVD risk factors. Gretchen Benson, RD, CDE, Healthcare Systems Integration ...

Adults with inherited high cholesterol are underdiagnosed and undertreated

2014-03-31
MINNEAPOLIS, MN – March 30, 2014 – An estimated 1 in 500 people worldwide suffer from familial hypercholesterolaemia (FH), an inherited condition of extremely high cholesterol that is associated with premature heart disease and death. Despite this high prevalence, recent research funded by the Minneapolis Heart Institute Foundation (MHIF) confirms FH is underdiagnosed and undertreated. Thomas Knickelbine, MD, Preventive Cardiology Director at the Minneapolis Heart Institute at Abbott Northwestern Hospital, will present the results of research aimed at identifying just ...

Evolocumab superior to ezetimibe in lowering LDL cholesterol

2014-03-31
WASHINGTON (March 30, 2014) — Evolocumab, an injected form of a class of drugs called PCSK9 inhibitors that lower low-density lipoprotein cholesterol, also known as LDL-C or "bad cholesterol," outperformed ezetimibe with few side effects in patients unable to take statins, according to research from GAUSS-2 presented at the American College of Cardiology's 63rd Annual Scientific Session. High LDL cholesterol is considered a major risk factor for cardiovascular disease. Statins are commonly prescribed to reduce that risk. Currently ezetimibe is one of the few options ...

LAST 30 PRESS RELEASES:

Animated movie characters with strabismus are more likely to be villains, study finds

How retailers change ordering strategy when a supplier starts its own direct channel

Young coral use metabolic tricks to resist bleaching

Protecting tax whistleblowers pays off

Bioluminescent proteins made from scratch enable non-invasive, multi-functional biological imaging

New study links air pollution with higher rates of head and neck cancer

LSU researchers excavate earliest ancient Maya salt works

Building a diverse wildland fire workforce to meet future challenges

MBARI researchers discover remarkable new swimming sea slug in the deep sea

Decentralized social media ‘increases citizen empowerment’, says Oxford study

Validating an electronic frailty index in a national health system

Combination approach shows promise for treating rare, aggressive cancers

Raise the roof: How to reduce badminton birdie drift

Ouch! Commonalties found in pain vocalizations and interjections across cultures

Income-related disparities in mortality among young adults with type 2 diabetes

Medical board discipline of physicians for spreading medical misinformation

First-ever randomized clinical trial uses telehealth for suicide prevention

DNA packaging directly affects how fast DNA is copied in cells

Scientists develop advanced catalyst for self-driven seawater splitting with enhanced chloride resistance

City of Hope researchers discover why taking a mushroom supplement slows or prevents prostate cancer from getting worse

Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia

Early treatment for nerve tumors prevents serious problems, study finds

Study: Student absenteeism crisis may be hurting teacher job satisfaction

Medicaid enrollment continuity tied to lymphoma stage at diagnosis

INSEAD launches free Negotiation Course for the World

Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer

Goblet cells could be the guardians of the gut

Romania’s science journalists join forces on new reporting handbook 

SwRI-led team proposes new solar composition ratios that could reconcile longstanding questions

Sodium butyrate inhibits necroptosis by regulating MLKL via E2F1 in intestinal epithelial cells of liver cirrhosis

[Press-News.org] Wen Dan Tang improves insomnia-related anxiety